Search results

This guideline covers diagnosing and managing idiopathic pulmonary fibrosis in people aged 18 and over. It aims to improve the quality of life for people with idiopathic pulmonary fibrosis by helping healthcare professionals to diagnose the condition and provide effective symptom management.

Result type

Clinical guideline

Last updated

23 May 2017

Evidence-based recommendations on brentuximab vedotin (Adcetris) for treating relapsed or refractory systemic anaplastic large cell lymphoma in adults.

Result type

Technology appraisal guidance

Published

4 October 2017

Evidence-based recommendations on daratumumab (Darzalex) with bortezomib and dexamethasone for previously treated multiple myeloma in adults.

Result type

Technology appraisal guidance

Published

6 June 2023

Evidence-based recommendations on durvalumab (Imfinzi) with gemcitabine and cisplatin for treating locally advanced, unresectable, or metastatic biliary tract cancer in adults.

Result type

Technology appraisal guidance

Published

10 January 2024

Evidence-based recommendations on avapritinib (Ayvakyt) for treating advanced systemic mastocytosis in adults.

Result type

Technology appraisal guidance

Published

6 November 2024

Evidence-based recommendations on darolutamide (Nubeqa) for treating hormone-relapsed prostate cancer in adults at high risk of developing metastatic disease.

Result type

Technology appraisal guidance

Published

25 November 2020

Evidence-based recommendations on enzalutamide (Xtandi) for treating metastatic, hormone-relapsed prostate cancer for people in whom chemotherapy is not yet clinically indicated.

Result type

Technology appraisal guidance

Published

27 January 2016

Evidence-based recommendations on ENDURALIFE-powered CRT-D devices for treating heart failure.

Result type

Medical technologies guidance

Last updated

21 July 2021

Evidence-based recommendations on percutaneous retroperitoneal endoscopic necrosectomy. This involves inserting a thin telescope through a small cut in the side above the hip and using it to wash out and remove the dead tissue.

Result type

Interventional procedures guidance

Published

23 March 2011

This guideline covers the routine antenatal care that women and their babies should receive. It aims to ensure that pregnant women are offered regular check-ups, information and support.

Result type

NICE guideline

Published

19 August 2021

Evidence-based recommendations on finerenone (Kerendia) for stage 3 and 4 chronic kidney disease (with albuminuria) associated with type 2 diabetes in adults.

Result type

Technology appraisal guidance

Published

23 March 2023

Evidence-based recommendations on radiofrequency valvotomy for pulmonary atresia. This involves making a hole in the blocked valve, and inserting and inflating a small balloon to widen it.

Result type

Interventional procedures guidance

Published

27 October 2004

Evidence-based recommendations on avalglucosidase alfa (Nexviadyme) for Pompe disease.

Result type

Technology appraisal guidance

Published

24 August 2022

Evidence-based recommendations on fulvestrant (Faslodex) for treating locally advanced or metastatic (secondary), oestrogen-receptor positive breast cancer in postmenopausal women who have not had endocrine therapy before.

Result type

Technology appraisal guidance

Published

31 January 2018

Evidence-based recommendations on ticagrelor (Brilique) for treating acute coronary syndromes in adults.

Result type

Technology appraisal guidance

Published

26 October 2011